| 51 |
23041051 | The kinase RSK2 modulates the sensitivity of ovarian cancer cells to cisplatin. | 2013 Jan |
1 |
| 52 |
23042098 | MAPK signaling in cisplatin-induced death: predominant role of ERK1 over ERK2 in human hepatocellular carcinoma cells. | 2013 Jan |
12 |
| 53 |
23338561 | Antitumor properties of salinomycin on cisplatin-resistant human ovarian cancer cells in vitro and in vivo: involvement of p38 MAPK activation. | 2013 Apr |
1 |
| 54 |
23783141 | Activation of ERK1/2 and Akt is associated with cisplatin resistance in human lung cancer cells. | 2013 Jun |
7 |
| 55 |
24335178 | Potential molecular mechanisms for improved prognosis and outcome with neoadjuvant chemotherapy prior to laparoscopical radical hysterectomy for patients with cervical cancer. | 2013 |
1 |
| 56 |
22179790 | RNAi-mediated knockdown of ERK1/2 inhibits cell proliferation and invasion and increases chemosensitivity to cisplatin in human osteosarcoma U2-OS cells in vitro. | 2012 Apr |
2 |
| 57 |
21130731 | Acquisition of chemoresistance in intrahepatic cholangiocarcinoma cells by activation of AKT and extracellular signal-regulated kinase (ERK)1/2. | 2011 Feb 18 |
2 |
| 58 |
21444628 | Up-regulation of extracellular signal-regulated kinase 1/2-dependent thymidylate synthase and thymidine phosphorylase contributes to cisplatin resistance in human non-small-cell lung cancer cells. | 2011 Jul |
5 |
| 59 |
21687949 | Tubeimoside I sensitizes cisplatin in cisplatin-resistant human ovarian cancer cells (A2780/DDP) through down-regulation of ERK and up-regulation of p38 signaling pathways. | 2011 Sep-Oct |
1 |
| 60 |
19962780 | Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2. | 2010 Aug |
5 |
| 61 |
18661133 | Characterization of kinase suppressor of Ras-1 expression and anticancer drug sensitivity in human cancer cell lines. | 2009 Apr |
1 |
| 62 |
19428505 | Role of MAPKs in platinum-induced neuronal apoptosis. | 2009 Mar |
1 |
| 63 |
17942395 | Epidermal growth factor receptor pathway analysis identifies amphiregulin as a key factor for cisplatin resistance of human breast cancer cells. | 2008 Jan 11 |
3 |
| 64 |
18093981 | A sensitive flow cytometry-based nucleotide excision repair assay unexpectedly reveals that mitogen-activated protein kinase signaling does not regulate the removal of UV-induced DNA damage in human cells. | 2008 Feb 29 |
1 |
| 65 |
18332870 | Cisplatin treatment increases survival and expansion of a highly tumorigenic side-population fraction by upregulating VEGF/Flt1 autocrine signaling. | 2008 Jun 26 |
2 |
| 66 |
18425342 | Constitutive activation of p70 S6 kinase is associated with intrinsic resistance to cisplatin. | 2008 May |
3 |
| 67 |
18544565 | Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, IressaR) and chemotherapeutic agents in human lung cancer cells. | 2008 Jul |
3 |
| 68 |
17023032 | A high nuclear basal level of ERK2 phosphorylation contributes to the resistance of cisplatin-resistant human ovarian cancer cells. | 2007 Feb |
1 |
| 69 |
17125914 | Activation of mitogen-activated protein kinases by cisplatin and their role in cisplatin-resistance. | 2007 Jun 18 |
2 |
| 70 |
17508026 | ERK1/2 is highly phosphorylated in melanoma metastases and protects melanoma cells from cisplatin-mediated apoptosis. | 2007 Sep |
1 |
| 71 |
17513610 | Expression of human glutathione S-transferase P1 mediates the chemosensitivity of osteosarcoma cells. | 2007 May |
2 |
| 72 |
17982682 | Erythropoietin reduces cisplatin-induced neurotoxicity without impairment of cytotoxic effects against tumor cells. | 2007 Dec |
2 |
| 73 |
16395709 | p38 MAPK turns hepatocyte growth factor to a death signal that commits ovarian cancer cells to chemotherapy-induced apoptosis. | 2006 Jun 15 |
2 |
| 74 |
16723633 | Polynuclear platinum anticancer drugs are more potent than cisplatin and induce cell cycle arrest in glioma. | 2006 Jul |
1 |
| 75 |
15843040 | Pharmacological inhibitors of extracellular signal-regulated protein kinases attenuate the apoptotic action of cisplatin in human myeloid leukemia cells via glutathione-independent reduction in intracellular drug accumulation. | 2005 Apr 15 |
3 |
| 76 |
16039614 | Activation of ERK during DNA damage-induced apoptosis involves protein kinase Cdelta. | 2005 Sep 9 |
2 |
| 77 |
15250250 | Role of ERK1/2 kinase in cisplatin-induced apoptosis in human ovarian carcinoma cells. | 2004 Jun |
2 |
| 78 |
12439598 | Ras-mediated activation of ERK by cisplatin induces cell death independently of p53 in osteosarcoma and neuroblastoma cell lines. | 2002 Nov |
1 |
| 79 |
11170260 | Cisplatin-induced response of c-jun N-terminal kinase 1 and extracellular signal--regulated protein kinases 1 and 2 in a series of cisplatin-resistant ovarian carcinoma cell lines. | 2000 Dec |
19 |
| 80 |
10353733 | Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin. | 1999 May |
11 |